Research graph
References from Modulation of sebocyte function in acne: A pathway‐inclusive review. Local targets link to admitted publications; unresolved targets remain external evidence.
10.2165/00003495‐200
10.2165/00003495‐200 · External reference
10.1067/mjd.2003.618
10.1067/mjd.2003.618 · External reference
10.1007/s13555‐021‐00552‐6
10.1007/s13555‐021‐00552‐6 · External reference
10.1007/s00403‐025‐03894‐9
10.1007/s00403‐025‐03894‐9 · External reference
10.3389/fimmu.2022.1029818
10.3389/fimmu.2022.1029818 · External reference
10.3390/bioengineering12121333
10.3390/bioengineering12121333 · External reference
Lipid dysregulation in sebaceous gland disorders and the impact of sphingolipid metabolism on acne pathogenesis
2025 · External reference
The sebaceous gland: a key player in the balance between homeostasis and inflammatory skin diseases
10.3390/cells14100747 · 2025 · External reference
10.1038/jid.2013.413
10.1038/jid.2013.413 · External reference
10.3390/biom12121858
10.3390/biom12121858 · External reference
10.1016/j.bbrep.2023.101578
10.1016/j.bbrep.2023.101578 · External reference
10.1080/13543784.2017.1337745
10.1080/13543784.2017.1337745 · External reference
10.36849/jdd.7000
10.36849/jdd.7000 · External reference
10.1007/s13555‐025‐01495‐y
10.1007/s13555‐025‐01495‐y · External reference
10.1111/jocd.15602
10.1111/jocd.15602 · External reference
1726 nm lasers for the treatment of acne vulgaris
2024 · External reference
10.4161/derm.1.2.7804
10.4161/derm.1.2.7804 · External reference
10.1046/j.1523‐1747.2000.00094.x
10.1046/j.1523‐1747.2000.00094.x · External reference
10.1080/19381980.2017.1361576
10.1080/19381980.2017.1361576 · External reference
10.1016/j.bcp.2017.04.030
10.1016/j.bcp.2017.04.030 · External reference
Insulin and the sebaceous gland function
10.3389/fphys.2023.1252972 · 2023 · External reference
10.1016/j.jtos.2018.07.004
10.1016/j.jtos.2018.07.004 · External reference
10.1046/j.1523‐1747.1999.00771.x
10.1046/j.1523‐1747.1999.00771.x · External reference
10.1111/exd.12172
10.1111/exd.12172 · External reference
10.1038/sj.jid.5700213
10.1038/sj.jid.5700213 · External reference
10.1038/sj.jid.5701155
10.1038/sj.jid.5701155 · External reference
Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet‐induced acne
10.1111/exd.12142 · 2013 · External reference
10.2147/ccid.s69135
10.2147/ccid.s69135 · External reference
10.1016/j.celrep.2023.113121
10.1016/j.celrep.2023.113121 · External reference
10.1016/j.jbc.2024.107442
10.1016/j.jbc.2024.107442 · External reference
10.1007/s11154‐016‐9389‐5
10.1007/s11154‐016‐9389‐5 · External reference
10.1080/19381980.2017.1375636
10.1080/19381980.2017.1375636 · External reference
10.1016/j.jdermsci.2017.11.006
10.1016/j.jdermsci.2017.11.006 · External reference
10.4161/derm.1.2.8472
10.4161/derm.1.2.8472 · External reference
Seasonal changes in epidermal ceramides are linked to impaired barrier function in acne patients
10.1111/exd.13499 · 2018 · External reference
10.1155/2010/321494
10.1155/2010/321494 · External reference
10.3390/ph16121704
10.3390/ph16121704 · External reference
10.1111/j.1468‐3083.2006.01663.x
10.1111/j.1468‐3083.2006.01663.x · External reference
10.4161/derm.1.3.8473
10.4161/derm.1.3.8473 · External reference
10.1155/2010/858176
10.1155/2010/858176 · External reference
10.4049/jimmunol.1800893
10.4049/jimmunol.1800893 · External reference
10.1111/exd.14172
10.1111/exd.14172 · External reference
10.1038/jid.2014.290
10.1038/jid.2014.290 · External reference
10.4103/ijd.ijd_483_16
10.4103/ijd.ijd_483_16 · External reference
10.21037/atm‐21‐5924
10.21037/atm‐21‐5924 · External reference
10.5021/ad.2021.33.6.541
10.5021/ad.2021.33.6.541 · External reference
10.1126/sciimmunol.abo2787
10.1126/sciimmunol.abo2787 · External reference
10.2147/ccid.s424478
10.2147/ccid.s424478 · External reference
10.3390/microorganisms11092183
10.3390/microorganisms11092183 · External reference
10.1111/jocd.15946
10.1111/jocd.15946 · External reference
10.1016/j.pharmthera.2024.108681
10.1016/j.pharmthera.2024.108681 · External reference
10.3389/fimmu.2024.1502242
10.3389/fimmu.2024.1502242 · External reference
10.1016/j.jid.2025.04.041
10.1016/j.jid.2025.04.041 · External reference
10.2147/ccid.s392165
10.2147/ccid.s392165 · External reference
10.1186/s40168‐018‐0558‐5
10.1186/s40168‐018‐0558‐5 · External reference
10.1080/09546634.2023.2298878
10.1080/09546634.2023.2298878 · External reference
10.1111/jdv.12061
10.1111/jdv.12061 · External reference
10.3892/etm.2021.11074
10.3892/etm.2021.11074 · External reference
10.1210/jendso/bvac003
10.1210/jendso/bvac003 · External reference
10.1038/sj.jid.5700278
10.1038/sj.jid.5700278 · External reference
10.1093/ajcn/86.1.107
10.1093/ajcn/86.1.107 · External reference
10.1073/pnas.102180999
10.1073/pnas.102180999 · External reference
10.1111/j.1365‐2133.2008.08958.x
10.1111/j.1365‐2133.2008.08958.x · External reference
10.1016/j.bbi.2023.12.005
10.1016/j.bbi.2023.12.005 · External reference
10.4161/derm.1.3.9666
10.4161/derm.1.3.9666 · External reference
10.2340/00015555‐2376
10.2340/00015555‐2376 · External reference
10.1038/s41467‐022‐28
10.1038/s41467‐022‐28 · External reference
10.2147/ijgm.s421835
10.2147/ijgm.s421835 · External reference
10.1038/s41431‐023‐01326‐8
10.1038/s41431‐023‐01326‐8 · External reference
10.1111/bjd.17721
10.1111/bjd.17721 · External reference
10.4161/derm.1.3.8474
10.4161/derm.1.3.8474 · External reference
10.3389/fmed.2017.00016
10.3389/fmed.2017.00016 · External reference
The genetics of acne
10.1111/ahg.70014 · 2025 · External reference
Acne transcriptomics: fundamentals of acne pathogenesis and isotretinoin treatment
10.3390/cells12222600 · 2023 · External reference
10.1016/j.xjidi.2024.100306
10.1016/j.xjidi.2024.100306 · External reference
10.4161/derm.19828
10.4161/derm.19828 · External reference
10.1016/j.jdin.2022.02.012
10.1016/j.jdin.2022.02.012 · External reference
10.1186/1471‐5945‐12‐13
10.1186/1471‐5945‐12‐13 · External reference
10.5021/ad.24.159
10.5021/ad.24.159 · External reference
10.2147/ccid.s131323
10.2147/ccid.s131323 · External reference
10.1016/j.ijwd.2020.11.001
10.1016/j.ijwd.2020.11.001 · External reference
10.36849/jdd.5608
10.36849/jdd.5608 · External reference
10.1093/skinhd/vzaf090
10.1093/skinhd/vzaf090 · External reference
10.1155/drp/9910076
10.1155/drp/9910076 · External reference
Acne and the cutaneous microbiome: a systematic review of mechanisms and implications for treatments
10.1111/jdv.20332 · 2025 · External reference
10.1186/s13578‐023‐01072‐w
10.1186/s13578‐023‐01072‐w · External reference
10.1111/jdv.19540
10.1111/jdv.19540 · External reference
10.1111/exd.14467
10.1111/exd.14467 · External reference
10.3390/microorganisms8111752
10.3390/microorganisms8111752 · External reference
10.1093/skinhd/vzaf077
10.1093/skinhd/vzaf077 · External reference
10.3390/microorganisms10071303
10.3390/microorganisms10071303 · External reference
10.1111/srt.13473
10.1111/srt.13473 · External reference
10.7759/cureus.97010
10.7759/cureus.97010 · External reference
10.3390/life12030422
10.3390/life12030422 · External reference
10.3390/ijms25105302
10.3390/ijms25105302 · External reference
10.1007/s43657‐022‐00073‐y
10.1007/s43657‐022‐00073‐y · External reference
10.3390/molecules30244684
10.3390/molecules30244684 · External reference
10.3390/ijms252111422
10.3390/ijms252111422 · External reference
10.1016/j.jdin.2023.03.013
10.1016/j.jdin.2023.03.013 · External reference
10.1111/j.1468‐3083.2011.04374.x
10.1111/j.1468‐3083.2011.04374.x · External reference
10.7759/cureus.56596
10.7759/cureus.56596 · External reference
10.1007/s40257‐023‐00789‐1
10.1007/s40257‐023‐00789‐1 · External reference
10.3389/fmed.2024.1425675
10.3389/fmed.2024.1425675 · External reference
50 years of topical retinoids for acne: evolution of treatment
10.1007/s40257-021-00594-8 · 2021 · External reference
10.3390/pharmaceutics11100490
10.3390/pharmaceutics11100490 · External reference
10.1111/jdv.20154
10.1111/jdv.20154 · External reference
10.1007/s13555‐025‐01344‐y
10.1007/s13555‐025‐01344‐y · External reference
Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne
10.1016/j.jaad.2019.02.044 · 2019 · External reference
Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne
10.1111/jdv.15794 · 2020 · External reference
10.1016/s0149‐2918(02)80023‐6
10.1016/s0149‐2918(02)80023‐6 · External reference
10.1001/archderm.1984.01650390073015
10.1001/archderm.1984.01650390073015 · External reference
Clindamycin: a comprehensive status report with emphasis on use in dermatology
2024 · External reference
10.1016/j.jaad.2015.12.037
10.1016/j.jaad.2015.12.037 · External reference
10.3390/antibiotics13030270
10.3390/antibiotics13030270 · External reference
10.1111/jocd.15923
10.1111/jocd.15923 · External reference
10.5114/ada.2023.133955
10.5114/ada.2023.133955 · External reference
Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports
1996 · External reference
10.1111/jebm.12411
10.1111/jebm.12411 · External reference
A randomized investigator‐blind parallel‐group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne
10.1111/jdv.12823 · 2015 · External reference
Azelaic acid reduced senescence‐like phenotype in photo‐irradiated human dermal fibroblasts: possible implication of PPARγ
10.1111/exd.12066 · 2013 · External reference
Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation
10.1111/j.1600-0625.2010.01107.x · 2010 · External reference
Individual article: Clascoterone cream 1%: mechanism of action, efficacy, and safety of a novel, first‐in‐class topical antiandrogen therapy for acne
2023 · External reference
10.1001/jamadermatol.2020.0465
10.1001/jamadermatol.2020.0465 · External reference
10.36849/jdd.7592
10.36849/jdd.7592 · External reference
10.1016/j.jaad.2020.04.087
10.1016/j.jaad.2020.04.087 · External reference
10.1002/14651858.cd009435.pub2
10.1002/14651858.cd009435.pub2 · External reference
10.2147/dddt.s427530
10.2147/dddt.s427530 · External reference
10.4103/2277‐9175.129693
10.4103/2277‐9175.129693 · External reference
10.4103/2229‐5178.190505
10.4103/2229‐5178.190505 · External reference
An open‐label, phase IV study evaluating Lidose‐isotretinoin administered without food in patients with severe recalcitrant nodular acne: low relapse rates observed over the 104‐week post‐treatment period
2019 · External reference
10.5114/ada.2025.153322
10.5114/ada.2025.153322 · External reference
10.1111/dth.14438
10.1111/dth.14438 · External reference
Isotretinoin revisited: pluripotent effects on human sebaceous gland cells
10.1038/sj.jid.5700418 · 2006 · External reference
10.1016/j.jaad.2023.12.017
10.1016/j.jaad.2023.12.017 · External reference
Oral tetracyclines and acne: a systematic review for dermatologists
2020 · External reference
10.2217/fmb‐2019‐0199
10.2217/fmb‐2019‐0199 · External reference
10.1002/14651858.cd002086.pub2
10.1002/14651858.cd002086.pub2 · External reference
10.1007/s40257‐016‐0245‐x
10.1007/s40257‐016‐0245‐x · External reference
10.2147/ccid.s114830
10.2147/ccid.s114830 · External reference
10.1136/bmj‐2022‐074349
10.1136/bmj‐2022‐074349 · External reference
Unresolved reference
2012 · External reference
Hormonal antiandrogens in acne treatment
2010 · External reference
10.1111/jdv.16252
10.1111/jdv.16252 · External reference
10.1111/bjd.21663
10.1111/bjd.21663 · External reference
10.1002/cpdd.644
10.1002/cpdd.644 · External reference
10.1016/j.jaad.2016.08.053
10.1016/j.jaad.2016.08.053 · External reference
10.1016/j.jid.2017.01.026
10.1016/j.jid.2017.01.026 · External reference
10.1111/dth.12953
10.1111/dth.12953 · External reference
10.3390/ph16010027
10.3390/ph16010027 · External reference
10.2147/ccid.s571984
10.2147/ccid.s571984 · External reference
10.1007/s00403‐024‐03585‐x
10.1007/s00403‐024‐03585‐x · External reference
10.3390/ijms26146745
10.3390/ijms26146745 · External reference
10.1016/j.abd.2025.501249
10.1016/j.abd.2025.501249 · External reference
10.1371/journal.pone.0001551
10.1371/journal.pone.0001551 · External reference
10.1371/journal.pone.0014797
10.1371/journal.pone.0014797 · External reference
10.1016/j.jid.2018.05.032
10.1016/j.jid.2018.05.032 · External reference
Functional divergence of a bacterial enzyme promotes healthy or acneic skin
10.1038/s41467-023-43833-8 · 2023 · External reference
Treatment of acne with a 1726 nm laser, air cooling, and real‐time temperature monitoring, software‐assisted power adjustment to achieve a temperature endpoint with selective sebaceous gland Photothermolysis
10.1002/lsm.23872 · 2025 · External reference
Stem cell membrane‐coated Au‐Ag‐PDA nanoparticle‐guided photothermal acne therapy
10.1016/j.colsurfb.2020.111145 · 2020 · External reference
Dissolving hyaluronic acid‐based microneedles to Transdermally deliver eugenol combined with photothermal therapy for acne vulgaris treatment
10.1021/acsami.4c01790 · 2024 · External reference
Novel 1726 nm laser demonstrates durable therapeutic outcomes and tolerability for moderate‐to‐severe acne across skin types
10.1016/j.jaad.2023.05.085 · 2023 · External reference
10.1016/j.jaad.2025.09.077
10.1016/j.jaad.2025.09.077 · External reference
A call to limit antibiotic use in acne
2013 · External reference
10.1016/s1473‐3099(15)00527‐7
10.1016/s1473‐3099(15)00527‐7 · External reference
10.1111/jdv.70331
10.1111/jdv.70331 · External reference
The dark side of Oral antibiotics: adverse events of consideration in dermatology
10.36849/jdd.99182 · 2025 · External reference
10.1002/ski2.240
10.1002/ski2.240 · External reference
Optimal use recommendations and stewardship principles with Oral antibiotics in acne vulgaris management: An expert consensus panel
2025 · External reference
10.3390/antibiotics14080844
10.3390/antibiotics14080844 · External reference
10.1001/jamadermatol.2024.5416
10.1001/jamadermatol.2024.5416 · External reference
10.1159/000350820
10.1159/000350820 · External reference
10.1016/j.jid.2025.04.032
10.1016/j.jid.2025.04.032 · External reference
10.1016/j.jid.2025.02.012
10.1016/j.jid.2025.02.012 · External reference
10.1038/s41598‐021‐96
10.1038/s41598‐021‐96 · External reference
10.1111/nyas.14615
10.1111/nyas.14615 · External reference
10.1111/ced.12794
10.1111/ced.12794 · External reference
10.3389/fimmu.2024.1275269
10.3389/fimmu.2024.1275269 · External reference
10.3389/fimmu.2024.1522076
10.3389/fimmu.2024.1522076 · External reference
10.1038/s41590‐025‐02267‐8
10.1038/s41590‐025‐02267‐8 · External reference
10.1016/j.jid.2017.04.017
10.1016/j.jid.2017.04.017 · External reference
10.1111/bjd.19675
10.1111/bjd.19675 · External reference
10.1007/978-3-030-68996-4_3
10.1007/978-3-030-68996-4_3 · 2021 · External reference
10.1016/j.chom.2024.06.002
10.1016/j.chom.2024.06.002 · External reference
10.1001/jamadermatol.2023.0269
10.1001/jamadermatol.2023.0269 · External reference
10.1016/j.clindermatol.2020.10.016
10.1016/j.clindermatol.2020.10.016 · External reference
The efficacy of anti‐IL‐1 targeted therapy in PAPA and PASH syndrome
10.1002/jvc2.52 · 2022 · External reference
Novel and off‐label biologic use in the Management of Hidradenitis Suppurativa, pyoderma gangrenosum, lichen planus, and seborrheic dermatitis: a narrative review
10.1007/s13555-022-00860-5 · 2023 · External reference
10.1016/j.jaad.2018.08.020
10.1016/j.jaad.2018.08.020 · External reference
10.1016/j.jaad.2006.10.005
10.1016/j.jaad.2006.10.005 · External reference
Efficacy, safety, and dermal tolerability of dapsone gel, 7.5% in patients with moderate acne vulgaris: a pooled analysis of two phase 3 trials
2016 · External reference
Once‐daily Oral Sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double‐blind clinical trials
2018 · External reference
10.1016/j.contraception.2007.11.003
10.1016/j.contraception.2007.11.003 · External reference
